Follow on to: Preventing avoidable blindness through smart home-monitoring of vision

继续：通过智能家居视力监测预防可避免的失明

• 批准号: ES/Y001346/1
• 负责人: Peter Jones
• 金额: $ 12.85万
• 依托单位: City, University of London
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=ES%2FY001346%2F1
• 关键词: Follow; Preventing; avoidable; blindness; through; Follow; Preventing; avoidable; blindness; through

Glaucoma is the second leading cause of irreversible blindness. It affects 1 in 50 people over 40 years old, all of whom must currently travel to hospital once or twice a year for vision checks. Over 1M such "monitoring" assessments are carried out by the NHS every year.These hospital visits are not only inconvenient: they are unsustainable. Even before COVID, NHS backlogs meant that twenty patients a month were going blind due to delayed glaucoma appointments, and patient numbers are expected to double by 2030. Hospital-only monitoring is also insufficient for the 1 in 23 people with the most aggressive form of glaucoma. Such individuals are liable to experience sudden, irreversible sight loss between hospital appointments.The solution is home-monitoring. If people could check their own vision at home, then sight loss could be detected more quickly, conveniently, and cheaply. People could choose to test their vision more frequently, or when they started to notice a change: allowing sight loss to be flagged and treated sooner. Lower risk patients could attend fewer hospital appointments: reducing unnecessary travel, and freeing up resources to focus on those most in need. And by testing vision at home, more time in the clinic could be spent talking to the doctor face-to-face.That is why over the last eight years we have developed Eyecatcher: the world's first validated vision test for glaucoma home-monitoring. The challenge now is to scale up Eyecatcher, and get it into the hands of patients, in a sustainable, cost-effective way.We will use these present funds to translate Eyecatcher from an academic project to a sustainable, commercial venture.

青光眼是不可逆失明的第二大原因。它影响了40岁以上的50人中有1人，他们目前必须每年一次或两次去医院进行视力检查。每年NHS都会进行超过1M这样的“监测”评估。这些医院就诊不仅不便：它们是不可持续的。甚至在COVID之前，NHS积压都意味着由于青光眼任命的延迟，每月二十名患者视而不见，预计到2030年，患者人数预计将翻一番。仅医院的监测也不足以使23人中有23人中有最具侵略性的青光眼。这样的人有可能在医院约会之间经历突然的，不可逆转的视力丧失。解决方案是家庭监视的。如果人们可以在家中查看自己的愿景，那么可以更快，方便，便宜地检测到视力损失。人们可以选择更频繁地测试自己的愿景，或者当他们开始注意到变化时：允许对视力丧失进行标记和对待。降低风险的患者可以参加更少的医院约会：减少不必要的旅行，并释放资源以专注于最有需要的人。通过在家中测试视觉，可以在诊所与医生面对面交谈的更多时间。现在面临的挑战是以一种可持续的，具有成本效益的方式来扩大目击者，并将其交到患者手中。我们将使用这些目前的资金将目击者从学术项目转化为可持续的商业企业。